mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |